Containerboard production was 5.2% higher compared to July 2016. The month-over-month average daily production compared to June 2017 was 1.7% higher. The containerboard operating rate for July increased from 96.3% to 97.9%, which was 2.8 percentage points higher compared to July of last year. Year-to-date production of containerboard for export is up 6.3%.
http://afandpa.org/media/news/2017/08/17/american-forest-paper-association-releases-july-2017-containerboard-report
Related Posts
SunCure EcoPlast is a revolutionary new UV ink technology for plastic cup decoration that delivers high adhesion, fast cure speed, low migration properties and the ability to be washed off…
The American Forest & Paper Association (AF&PA) has released the December 2022 Packaging Papers Monthly report. According to the report, total U.S. packaging papers & specialty packaging shipments in December decreased 13% compared to December 2021. Total packaging papers & specialty packaging shipments were down 4% for the year compared to 2021. Shipments of the biggest subgrade in bleached packaging papers — food wrapping — were 27,000 short tons for the month of December. Unbleached packaging papers & specialty packaging shipments in December decreased 12% compared to December 2021. They were down 2% for the year compared to 2021.
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia. An inauguration ceremony held on December 1, 2023, marked the official opening of the new Aptar Mumbai production facility in the Palava Industrial and Logistics Park at Taloja, Mumbai. Members of Aptar’s Executive Committee and Aptar Pharma’s Global Leadership Team welcomed more than 100 key customers and Aptar employees from the Mumbai and Hyderabad, India sites to this momentous occasion, which included a ribbon cutting and tree-planting ceremony. Manufacturing capabilities at Aptar Mumbai, which began in 2012 with the assembly and supply of metered dose valves and pumps, have now been expanded to offer more innovative product solutions and ensure increased manufacturing capacity to pharma customers in South East Asia.